OpenURL Connection Search

Select item for more details and to access through your institution.

Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 1, p. 261, doi. 10.1002/alz.12651
By:
- Brody, Mark;
- Agronin, Marc;
- Herskowitz, Brad J.;
- Bookheimer, Susan Y.;
- Small, Gary W.;
- Hitchinson, Benjamin;
- Ramdas, Kevin;
- Wishard, Tyler;
- McInerney, Katalina Fernández;
- Vellas, Bruno;
- Sierra, Felipe;
- Jiang, Zhijie;
- Mcclain‐Moss, Lisa;
- Perez, Carmen;
- Fuquay, Ana;
- Rodriguez, Savannah;
- Hare, Joshua M.;
- Oliva, Anthony A.;
- Baumel, Bernard
Publication type:
Article
The Effects of Multiple Doses of Lomecel‐B, Longeveron' s Cell‐based Therapy, on Alzheimer's disease: Study Design and Rationale of this Phase 2a Multi‐ center Clinical trial.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.067168
By:
- Ramdas, Kevin N.;
- Brody, Mark;
- Herskowitz, Brad;
- Agronin, Marc;
- Ruiz, Jorge G;
- Fuquay, Ana;
- Rodriguez, Savannah;
- Mehranfard, Danial;
- McClain‐Moss, Lisa;
- Gincel, Dan;
- Hare, Joshua M.;
- Oliva, Anthony A.
Publication type:
Article
Safety and efficacy of Lomecel‐B in patients with mild Alzheimer's disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057581
By:
- Oliva, Anthony A.;
- Brody, Mark;
- Agronin, Marc;
- Herskowitz, Brad;
- Bookheimer, Susan Y;
- Hitchinson, Ben;
- Ramdas, Kevin;
- Wishard, Tyler;
- McClain‐Moss, Lisa;
- Diaz, Liliana A.;
- Yousefi, Keyvan;
- Perez, Carmen;
- Fuquay, Ana;
- Rodriguez, Savannah;
- Hare, Joshua M.;
- Baumel, Bernard
Publication type:
Article
Clinical evaluation of allogeneic mesenchymal stem cells for Alzheimer's disease: Human/Human trials: Inflammation.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046634
By:
- Oliva, Anthony A.;
- Baumel, Bernard;
- Brody, Mark;
- Agronin, Marc;
- Herskowitz, Brad;
- Bookheimer, Susan Y;
- McClain‐Moss, Lisa;
- Hitchinson, Ben;
- Ramdas, Kevin;
- Pena, Andrea;
- Diaz, Liliana A.;
- Green, Geoff;
- Perez, Carmen;
- Fuquay, Ana;
- Castaneda, Ricardo;
- Rodriguez, Savannah;
- Delucca, Johanna;
- Hare, Joshua M.
Publication type:
Article

Found: 4

Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease.

The Effects of Multiple Doses of Lomecel‐B, Longeveron' s Cell‐based Therapy, on Alzheimer's disease: Study Design and Rationale of this Phase 2a Multi‐ center Clinical trial.

Safety and efficacy of Lomecel‐B in patients with mild Alzheimer's disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial.

Clinical evaluation of allogeneic mesenchymal stem cells for Alzheimer's disease: Human/Human trials: Inflammation.